DE69712642T2 - Transdermale anwendung von natürlich auftretenden steroid hormonen - Google Patents

Transdermale anwendung von natürlich auftretenden steroid hormonen

Info

Publication number
DE69712642T2
DE69712642T2 DE69712642T DE69712642T DE69712642T2 DE 69712642 T2 DE69712642 T2 DE 69712642T2 DE 69712642 T DE69712642 T DE 69712642T DE 69712642 T DE69712642 T DE 69712642T DE 69712642 T2 DE69712642 T2 DE 69712642T2
Authority
DE
Germany
Prior art keywords
steroid hormones
transdermal application
natural steroid
natural
transdermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69712642T
Other languages
English (en)
Other versions
DE69712642D1 (de
Inventor
Carolyn V Shaak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69712642D1 publication Critical patent/DE69712642D1/de
Application granted granted Critical
Publication of DE69712642T2 publication Critical patent/DE69712642T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69712642T 1996-07-12 1997-07-10 Transdermale anwendung von natürlich auftretenden steroid hormonen Expired - Fee Related DE69712642T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2189496P 1996-07-12 1996-07-12
US08/889,529 US6228852B1 (en) 1996-07-12 1997-07-08 Transdermal application of naturally occurring steroid hormones
PCT/US1997/011912 WO1998002167A1 (en) 1996-07-12 1997-07-10 Transdermal application of naturally occurring steriod hormones

Publications (2)

Publication Number Publication Date
DE69712642D1 DE69712642D1 (de) 2002-06-20
DE69712642T2 true DE69712642T2 (de) 2003-01-02

Family

ID=26695220

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69712642T Expired - Fee Related DE69712642T2 (de) 1996-07-12 1997-07-10 Transdermale anwendung von natürlich auftretenden steroid hormonen

Country Status (5)

Country Link
US (1) US6228852B1 (de)
EP (1) EP0963201B1 (de)
AU (1) AU3654697A (de)
DE (1) DE69712642T2 (de)
WO (1) WO1998002167A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5180583A1 (es) * 1999-06-11 2002-07-30 Watson Pharmaceuticals Inc Administracion de esteroides androgenicos no orales a las mujeres
AU2004222794B2 (en) * 1999-06-11 2007-03-08 Watson Pharmaceuticals, Inc. Non-oral androgenic steroids for women
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US7572780B2 (en) * 2003-01-21 2009-08-11 Dimera, Incorporated Method and kit for reducing the symptoms of peripheral vascular disease
WO2004078092A2 (en) * 2003-02-28 2004-09-16 Waikiwi Corporation Cream dispenser
US20070167418A1 (en) * 2004-09-07 2007-07-19 Ferguson Steven W Progesterone/testosterone cream for erectile dysfunction
RS52671B (en) 2005-10-12 2013-06-28 Unimed Pharmaceuticals Llc IMPROVED TESTOSTERON GEL AND USE PROCEDURE
US20100178323A1 (en) 2007-07-10 2010-07-15 Agis Kydonieus Dermal Delivery Device
US9198876B2 (en) 2008-10-08 2015-12-01 Agile Therapeutics, Inc. Contraceptive transdermal delivery of hormones
CA2740004A1 (en) 2008-10-08 2010-04-15 Agile Therapeutics, Inc. Transdermal delivery
CA2740005C (en) 2008-10-08 2016-11-01 Agile Therapeutics, Inc. Transdermal delivery
EP2410859A4 (de) 2009-03-27 2013-03-13 Agile Therapeutics Inc Transdermale freisetzung
US8658628B2 (en) * 2009-06-18 2014-02-25 Karan Y. Baucom Hormone delivery system and method
US9795617B2 (en) 2009-06-18 2017-10-24 Baucom Institute for Longevity and Life Enhancement, Inc. Hormone delivery system and method
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9610392B2 (en) 2012-06-08 2017-04-04 Fresenius Medical Care Holdings, Inc. Medical fluid cassettes and related systems and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
BR112016029338A2 (pt) 2014-07-29 2017-08-22 Therapeuticsmd Inc creme transdérmico
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10285998B1 (en) 2018-04-04 2019-05-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177267A (en) * 1963-12-09 1979-12-04 Crown Zellerbach Enhancing tissue penetration of physiologically active steroidal agents with DMSC
US4150128A (en) * 1976-03-15 1979-04-17 Jasionowski Edward A Method of treating atrophic vulvar dystrophy
US4436738A (en) * 1982-03-15 1984-03-13 Mead Johnson & Company Stabilized estradiol cream composition
US4542129A (en) * 1982-08-16 1985-09-17 Norman Orentreich DHEA Formulations and methods for treating dry skin
US4628052A (en) * 1985-05-28 1986-12-09 Peat Raymond F Pharmaceutical compositions containing dehydroepiandrosterone and other anesthetic steroids in the treatment of arthritis and other joint disabilities
US4762717A (en) * 1986-03-21 1988-08-09 The General Hospital Corporation Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive
US5059426A (en) * 1989-03-22 1991-10-22 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
ATE275957T1 (de) 1993-01-19 2004-10-15 Endorech Inc Therapeutische verwendungen und verabreichungsysteme von dehydroepiandrosteron
US5776923A (en) * 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
US5407944A (en) * 1993-02-19 1995-04-18 Goldman; Boris E. Compositions and methods for promoting hair growth
US5460820B1 (en) 1993-08-03 1999-08-03 Theratech Inc Method for providing testosterone and optionally estrogen replacement therapy to women
FR2729854A1 (fr) 1995-01-26 1996-08-02 Oreal Utilisation du sulfate de dehydroepi-androsterone dans une composition cosmetique ou dermatologique
ES2098193B1 (es) 1995-07-21 1997-12-01 Gomez Jesus Calderon Nueva formulacion farmaceutica de dehidroepiandrosterona para aplicacion topica percutanea.
US5709878A (en) * 1996-08-02 1998-01-20 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone

Also Published As

Publication number Publication date
EP0963201A4 (de) 2000-04-26
EP0963201A1 (de) 1999-12-15
AU3654697A (en) 1998-02-09
EP0963201B1 (de) 2002-05-15
DE69712642D1 (de) 2002-06-20
US6228852B1 (en) 2001-05-08
WO1998002167A1 (en) 1998-01-22

Similar Documents

Publication Publication Date Title
DE69712642T2 (de) Transdermale anwendung von natürlich auftretenden steroid hormonen
FI962932A (fi) Ankkuriproteiinifunktion modulaattoreita
DE69628448D1 (de) Transdermale verabreichungsform von flurbiprofen
DE69530004D1 (de) Transdermale verabreichung von apomorphin
DE69838386D1 (de) Beleuchtungssystem und dessen anwendung
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
DE69835020D1 (de) Plasmabrenner und verwendungsverfahren dieses plasmabrenners
DE69842004D1 (de) Substituierte 2-aminoacetamide und anwendung davon
DE69634998D1 (de) Kontrolle von Kanten
DE69839096D1 (de) Dispersion von cellulose
DE69533361D1 (de) Umsetzung von kohlenwasserstoffen
NO960586D0 (no) Öket tverrbinding av naturlig vev
DE69822272D1 (de) Dynamische Ausbreitung von Druckfähigkeiten
DE69907705D1 (de) Verschachteler mit anwendung von nebengruppenverteilung
FI980246A (fi) Menetelmä keittimen käyttämiseksi ja keitin
DE69632258D1 (de) Verminderung von schlechten geruchen
DE69803531D1 (de) Niederdruck-hydroxydealkylierung von ethylbenzol und xylol-isomerisierung
DE69633106D1 (de) Dermatologische anwendung von vitamin d derivate
DE69717677T2 (de) Koproduktion von perfluormethylperfluorvinylether und perfluorethylperfluorvinylether
DE69738967D1 (de) Stabile expression von tripelhelikalen proteinen
DE69620474T2 (de) Mikrobielle 11alpha-hydroxylierung von steroiden
DE59709922D1 (de) Pflaster zur transdermalen anwendung von pergolid
FI970157A (fi) Kuitulevyjen liimat ja menetelmä niiden valmistamiseksi
DE69820147D1 (de) Verbundbeschichtete Entwicklungselektroden und Verfahren dafür
DE69717846D1 (de) Behandlungsverfahren von laktamen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee